Abstract
BackgroundBiological therapies (BT) allowed a better control of disease activity in patients with Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA); however, its high cost may be a limitation to widespread...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have